Skip to Content

MYLAN 2036 MYLAN 2036 (Topiramate (sprinkle) 25 mg)

Pill with imprint MYLAN 2036 MYLAN 2036 is Pink, Capsule-shape and has been identified as Topiramate (sprinkle) 25 mg. It is supplied by Mylan Pharmaceuticals Inc..

Topiramate is used in the treatment of obesity; migraine prevention; fibromyalgia; borderline personality disorder; bipolar disorder (and more), and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 25 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for MYLAN 2036 MYLAN 2036

Topiramate (sprinkle)

Imprint:
MYLAN 2036 MYLAN 2036
Strength:
25 mg
Color:
Pink
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Carbonic anhydrase inhibitor anticonvulsants
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-2036

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide